Peripherally Inserted Central Catheters Market Size

Peripherally Inserted Central Catheters Market Size

Peripherally Inserted Central Catheters Market size was valued at around USD 1.3 billion in 2023 and is estimated to grow at 9.6% CAGR from 2024 to 2032. The increasing prevalence of infectious diseases and rising incidence of chronic conditions worldwide have propelled the demand for peripherally inserted central catheters (PICCs) globally.

To get key market trends

  Download Free Sample

Infectious diseases such as sepsis, pneumonia, and bloodstream infections often require prolonged intravenous therapy, necessitating the use of PICCs for reliable and long-term venous access. Additionally, the growing burden of chronic conditions such as cancer, kidney disease, and autoimmune disorders has led to an increase in the need for PICCs for chemotherapy, dialysis, and other treatments that require frequent or continuous infusion of medications and fluids.

For instance, according to Centers for Disease Control and Prevention (CDC), in 2019, there were 201,092 deaths in the U.S. involving sepsis, with three-fourths of those deaths occurring among persons aged 65 and over. These statistics underscore the growing demand for PICCs as a vital tool in managing both infectious diseases and chronic conditions, driving market growth for these catheters on a global scale.

Peripherally inserted central catheters (PICCs) are long, flexible tubes inserted into a peripheral vein, usually in the arm, and threaded through the vein until the tip reaches a large central vein near the heart, such as the superior vena cava or the inferior vena cava. PICCs are used to administer medications, fluids, blood products, or nutrients over an extended period, typically weeks to months, and can also be used for blood draws and to monitor central venous pressure.